Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn’s disease

Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn’s disease

Abstract Objective The incidence of adverse events in myeloablative transplant protocols is high in refractory Crohn’s disease; this study used low doses of cyclophosphamide. Fourteen patients were submitted to non-myeloablative autologous hematopoietic stem cell transplantation. Results The average...

Full description

Bibliographic Details
Main Authors: Milton Artur Ruiz, Roberto Luiz Kaiser, Luiz Gustavo de Quadros, Lilian Piron-Ruiz, Tatiana Peña-Arciniegas, Mikaell Alexandre Gouvea Faria, Rubens Camargo Siqueira, Flavio Fontes Pirozzi, Fernanda Soubhia Liedtke Kaiser, Richard K. Burt
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Research Notes
Online Access:http://link.springer.com/article/10.1186/s13104-017-2824-1

Internet

http://link.springer.com/article/10.1186/s13104-017-2824-1

Similar Items